Next, to validate that Exo-PD-1 attenuates tumor cell-induced T cell dysfunction via the interaction with cell-surface PD-L1, we needed to confirm the binding between Exo-PD-1 and cellular PD-L1 first. Here, CD274 is linked to neoplasm.